A new study, published in the New England Medical Journal shows that a drug produced by Genzyme and partner Bayer AG to combat leukaemia considerably reduces the risk of relapse in early Multiple Sclerosis. Scientists at Cambridge University hope the research will lead to improved treatment for the many sufferers of MS worldwide.
CK Science has a number of vacancies in scientific research and development, click here for more details.
Tags: MS, research jobs
There is new research out that raises hope for individuals stricken with multiple sclerosis. The study, which examines the effectiveness of IVIG on treatment of MS patients, shows that a drug treatment can slow the development of symptoms and the damage the disease does to the brain.Visit the website to read click here read more on multiple sclerosis